Samala, G. ., Devi, P. ., Saxena, S. ., Meda, N. ., Yogeeswari, P. ., & Sriram, D. . (2016). Design, synthesis and biological evaluation of imidazo 2,1-b thiazole and benzo d imidazo 2,1-b thiazole derivatives as Mycobacterium tuberculosis pantothenate synthetase inhibitors. Bioorganic & Medicinal Chemistry, 24(6), 1298-307. https://doi.org/10.1016/j.bmc.2016.01.059 (Original work published 2016)
PB Devi
First name:
PB
Last name:
Devi
Devi, P. ., Sridevi, J. ., Kakan, S. ., Saxena, S. ., Jeankumar, V. ., , … Sriram, D. . (2015). Discovery of novel lysine ɛ-aminotransferase inhibitors: An intriguing potential target for latent tuberculosis. Tuberculosis (Edinburgh, Scotland), 95(6), 786-794. https://doi.org/10.1016/j.tube.2015.04.010
Devi, P. ., Jogula, S. ., Reddy, A. ., Saxena, S. ., Sridevi, J. ., Sriram, D. ., & Yogeeswari, P. . (2015). Design of Novel Mycobacterium tuberculosis Pantothenate Synthetase Inhibitors: Virtual Screening, Synthesis and In Vitro Biological Activities. Molecular Informatics, 34(2-3), 147-59. https://doi.org/10.1002/minf.201400120
Saxena, S. ., Samala, G. ., Sridevi, J. ., Devi, P. ., Yogeeswari, P. ., & Sriram, D. . (2015). Design and development of novel Mycobacterium tuberculosis L-alanine dehydrogenase inhibitors. European Journal of Medicinal Chemistry, 92, 401-14. https://doi.org/10.1016/j.ejmech.2014.12.046 (Original work published 2015)
Pedgaonkar, G. ., Sridevi, J. ., Jeankumar, V. ., Saxena, S. ., Devi, P. ., Renuka, J. ., … Sriram, D. . (2014). Development of benzo d oxazol-2(3H)-ones derivatives as novel inhibitors of Mycobacterium tuberculosis InhA. Bioorganic & Medicinal Chemistry, 22(21), 6134-45. https://doi.org/10.1016/j.bmc.2014.08.031 (Original work published 2014)
Pedgaonkar, G. ., Sridevi, J. ., Jeankumar, V. ., Saxena, S. ., Devi, P. ., Renuka, J. ., … Sriram, D. . (2014). Development of 2-(4-oxoquinazolin-3(4H)-yl)acetamide derivatives as novel enoyl-acyl carrier protein reductase (InhA) inhibitors for the treatment of tuberculosis. European Journal of Medicinal Chemistry, 86, 613-27. https://doi.org/10.1016/j.ejmech.2014.09.028 (Original work published 2014)
Devi, P. ., Samala, G. ., Sridevi, J. ., Saxena, S. ., Alvala, M. ., Salina, E. ., … Yogeeswari, P. . (2014). Structure-guided design of thiazolidine derivatives as Mycobacterium tuberculosis pantothenate synthetase inhibitors. ChemMedChem, 9(11), 2538-47. https://doi.org/10.1002/cmdc.201402171
Samala, G. ., Nallangi, R. ., Devi, P. ., Saxena, S. ., Yadav, R. ., Sridevi, J. ., … Sriram, D. . (2014). Identification and development of 2-methylimidazo 1,2-a pyridine-3-carboxamides as Mycobacterium tuberculosis pantothenate synthetase inhibitors. Bioorganic & Medicinal Chemistry, 22(15), 4223-32. https://doi.org/10.1016/j.bmc.2014.05.038 (Original work published 2014)
Samala, G. ., Kakan, S. ., Nallangi, R. ., Devi, P. ., Sridevi, J. ., Saxena, S. ., … Sriram, D. . (2014). Investigating structure-activity relationship and mechanism of action of antitubercular 1-(4-chlorophenyl)-4-(4-hydroxy-3-methoxy-5-nitrobenzylidene) pyrazolidine-3,5-dione CD59 . International Journal of Mycobacteriology, 3(2), 117-26. https://doi.org/10.1016/j.ijmyco.2014.02.006
Samala, G. ., Devi, P. ., Nallangi, R. ., Sridevi, J. ., Saxena, S. ., Yogeeswari, P. ., & Sriram, D. . (2014). Development of novel tetrahydrothieno 2,3-c pyridine-3-carboxamide based Mycobacterium tuberculosis pantothenate synthetase inhibitors: molecular hybridization from known antimycobacterial leads. Bioorganic & Medicinal Chemistry, 22(6), 1938-47. https://doi.org/10.1016/j.bmc.2014.01.030 (Original work published 2014)
